Major Ingredients

Betamethasone BP 0.05%, Phenylephrine hydrochloride BP 0.1% & Lignocaine hydrochloride BP 2.5%

Major Functionality

Relitch is indicated for: relief of the symptoms of itching, irritation, discomfort or pain associated with local non-infective anal or peri-anal conditions such as external hemorrhoids.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.